{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:35:55Z","timestamp":1793723755524,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG033032-01"],"award-info":[{"award-number":["R01 AG033032-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1 K08 AG029157-01A1"],"award-info":[{"award-number":["1 K08 AG029157-01A1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG046543"],"award-info":[{"award-number":["R01 AG046543"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1017\/s1041610224000711","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T05:35:18Z","timestamp":1726724118000},"page":"1232-1244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2"],"prefix":"10.1016","volume":"36","author":[{"given":"Shankar","family":"Tumati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Perin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-4299","authenticated-orcid":false,"given":"Paul B.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1921-9806","authenticated-orcid":false,"given":"Prasad R.","family":"Padala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Brawman-Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"van Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton P.","family":"Porsteinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7024-6637","authenticated-orcid":false,"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1017\/S1041610224000711_bb0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13195-022-00984-y","article-title":"Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimers disease","volume":"14","author":"Assun\u00e7\u00e3o","year":"2022","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1017\/S1041610224000711_bb0015","doi-asserted-by":"crossref","DOI":"10.1201\/9781315369266-19","article-title":"Inference in semiparametric models","author":"Bickel","year":"2015"},{"issue":"3","key":"10.1017\/S1041610224000711_bb0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/01688639708403872","article-title":"Effect on measurement error on tests of statistical significance","volume":"19","author":"Charter","year":"1997","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"issue":"1","key":"10.1017\/S1041610224000711_bb0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1176\/jnp.2007.19.1.57","article-title":"Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale","volume":"19","author":"Clarke","year":"2007","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"1","key":"10.1017\/S1041610224000711_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychological Bulletin"},{"issue":"4","key":"10.1017\/S1041610224000711_bb0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jagp.2020.07.011","article-title":"The role of neuropsychiatric symptoms in research diagnostic criteria for neurodegenerative diseases","volume":"29","author":"Cummings","year":"2021","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"12","key":"10.1017\/S1041610224000711_bb0040","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"10","key":"10.1017\/S1041610224000711_bb0045","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/alz.12335","article-title":"Agitation in Alzheimers disease: novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria","volume":"17","author":"De Mauleon","year":"2021","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"issue":"6","key":"10.1017\/S1041610224000711_bb0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jagp.2012.12.018","article-title":"Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET)","volume":"21","author":"Drye","year":"2013","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"3","key":"10.1017\/S1041610224000711_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1017\/S1041610224000711_bb0060","author":"Food & Drug Administration","year":"2019","journal-title":"Incorporating clinical outcome assessments into endpoints for regulatory decision-making"},{"issue":"2","key":"10.1017\/S1041610224000711_bb0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0163278705275339","article-title":"Evaluating the statistical significance of health-related quality-of-life change in individual patients","volume":"28","author":"Hays","year":"2005","journal-title":"Evaluation & the Health Professions"},{"issue":"7","key":"10.1017\/S1041610224000711_bb0070","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/alz.12915","article-title":"Apathy in patients with Alzheimers disease is a cost-driving factor","volume":"19","author":"Kruse","year":"2023","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"issue":"1","key":"10.1017\/S1041610224000711_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jagp.2020.05.020","article-title":"Measuring apathy in Alzheimers disease in the apathy in dementia methylphenidate trial 2 (ADMET 2): a comparison of instruments","volume":"29","author":"Lanct\u00f4t","year":"2021","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"1","key":"10.1017\/S1041610224000711_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14283\/jpad.2022.102","article-title":"Establishing clinically meaningful change on outcome assessments frequently used in trials of mild cognitive impairment due to Alzheimers disease","volume":"10","author":"Lansdall","year":"2023","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"key":"10.1017\/S1041610224000711_bb0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuropsychologia.2017.07.003","article-title":"The anatomy of apathy: a neurocognitive framework for amotivated behaviour","volume":"118","author":"Le Heron","year":"2018","journal-title":"Neuropsychologia"},{"issue":"11","key":"10.1017\/S1041610224000711_bb0090","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0027-9684(15)31515-7","article-title":"Effectiveness and safety of donepezil in Hispanic patients with Alzheimers disease: a 12-week open-label study","volume":"100","author":"Lopez","year":"2008","journal-title":"Journal of the National Medical Association"},{"issue":"2","key":"10.1017\/S1041610224000711_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","article-title":"Reliability and validity of the Apathy Evaluation Scale","volume":"38","author":"Marin","year":"1991","journal-title":"Psychiatry Research"},{"issue":"7","key":"10.1017\/S1041610224000711_bb0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"6","key":"10.1017\/S1041610224000711_bb0105","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1017\/S1041610210000876","article-title":"The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia","volume":"22","author":"de Medeiros","year":"2010","journal-title":"International Psychogeriatrics"},{"issue":"12","key":"10.1017\/S1041610224000711_bb0110","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/alz.12358","article-title":"Diagnostic criteria for apathy in neurocognitive disorders","volume":"17","author":"Miller","year":"2021","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"issue":"11","key":"10.1017\/S1041610224000711_bb0115","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamaneurol.2021.3356","article-title":"Effect of methylphenidate on apathy in patients with Alzheimer disease: the ADMET 2 randomized clinical trial","volume":"78","author":"Mintzer","year":"2021","journal-title":"JAMA Neurology"},{"issue":"2","key":"10.1017\/S1041610224000711_bb0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jagp.2021.06.016","article-title":"Apathy as a treatment target in Alzheimers disease: implications for clinical trials","volume":"30","author":"Mortby","year":"2022","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"10","key":"10.1017\/S1041610224000711_bb0125","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/JGP.0b013e3182006a7f","article-title":"Predictors of family caregiver ratings of patient quality of life in Alzheimer disease: cross-sectional results from the Canadian Alzheimers Disease Quality of Life Study","volume":"19","author":"Naglie","year":"2011","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"5","key":"10.1017\/S1041610224000711_bb0130","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Medical Care"},{"issue":"2","key":"10.1017\/S1041610224000711_bb0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1176\/appi.ajp.2017.17030316","article-title":"Methylphenidate for apathy in community-dwelling older veterans with mild Alzheimers disease: a double-blind, randomized, placebo-controlled trial","volume":"175","author":"Padala","year":"2018","journal-title":"The American Journal of Psychiatry"},{"key":"10.1017\/S1041610224000711_bb0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.psychres.2017.12.063","article-title":"Repetitive transcranial magnetic stimulation for apathy in mild cognitive impairment: a double-blind, randomized, sham-controlled, cross-over pilot study","volume":"261","author":"Padala","year":"2018","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1017\/S1041610224000711_bb0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jalz.2019.09.074","article-title":"Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD","volume":"16","author":"Papp","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"issue":"2","key":"10.1017\/S1041610224000711_bb0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1017\/S1041610224000711_bb0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/alzrt48","article-title":"Review of Alzheimers disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?","volume":"2","author":"Robert","year":"2010","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"8","key":"10.1017\/S1041610224000711_bb0160","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4088\/JCP.12m08099","article-title":"Safety and efficacy of methylphenidate for apathy in Alzheimers disease: a randomized, placebo-controlled trial","volume":"74","author":"Rosenberg","year":"2013","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1017\/S1041610224000711_bb0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13063-017-2406-5","article-title":"The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial","volume":"19","author":"Scherer","year":"2018","journal-title":"Trials"},{"issue":"1","key":"10.1017\/S1041610224000711_bb0170","first-page":"e12017","article-title":"Composite cognitive and functional measures for early stage Alzheimers disease trials","volume":"12","author":"Schneider","year":"2020","journal-title":"Alzheimer\u2019s & Dementia (Amsterdam, Netherlands)"},{"issue":"1","key":"10.1017\/S1041610224000711_bb0175","first-page":"105","article-title":"Function and clinical meaningfulness of treatments for mild Alzheimers disease","volume":"2","author":"Siemers","year":"2016","journal-title":"Alzheimer\u2019s & Dementia (Amsterdam, Netherlands)"},{"issue":"3","key":"10.1017\/S1041610224000711_bb0180","first-page":"176","article-title":"An informant-based assessment of apathy in Alzheimer disease","volume":"15","author":"Strauss","year":"2002","journal-title":"Neuropsychiatry, Neuropsychology, and Behavioral Neurology"},{"issue":"5","key":"10.1017\/S1041610224000711_bb0185","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/alzrt210","article-title":"Progression of mild Alzheimers disease: knowledge and prediction models required for future treatment strategies","volume":"5","author":"Wattmo","year":"2013","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"6","key":"10.1017\/S1041610224000711_bb0190","doi-asserted-by":"crossref","first-page":"e0179521","DOI":"10.1371\/journal.pone.0179521","article-title":"Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: systematic review and consensus recommendations","volume":"12","author":"Webster","year":"2017","journal-title":"PloS One"},{"issue":"9","key":"10.1017\/S1041610224000711_bb0195","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0895-4356(99)00071-2","article-title":"Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life","volume":"52","author":"Wyrwich","year":"1999","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1017\/S1041610224000711_bb0200","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","article-title":"The prevalence of neuropsychiatric symptoms in Alzheimers disease: systematic review and meta-analysis","volume":"190","author":"Zhao","year":"2016","journal-title":"Journal of Affective Disorders"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610225002819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610225002819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610224000711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:42:36Z","timestamp":1778917356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610225002819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1041610225002819"],"URL":"https:\/\/doi.org\/10.1017\/s1041610224000711","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610224000711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 The Author(s), 2024. Published by Cambridge University Press on behalf of International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}